TORRENT PHARMACEUTICALS
Back to All Ratios
|
TORRENT PHARMACEUTICALS Last 5 Year Profit After Tax (PAT) Margin History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| PAT Margin (%) | 11.34 | 9.92 | 7.63 | 5.11 | 8.41 |
What is the latest Profit After Tax (PAT) Margin ratio of TORRENT PHARMACEUTICALS ?
| Year | Profit After Tax (PAT) Margin |
|---|---|
| Mar2025 | 11.34 |
| Mar2024 | 9.92 |
| Mar2023 | 7.63 |
| Mar2022 | 5.11 |
| Mar2021 | 8.41 |
How is Profit After Tax (PAT) Margin of TORRENT PHARMACEUTICALS Trending?
| Years | Profit After Tax (PAT) Margin | % Change | |
|---|---|---|---|
| Mar2025 | 11.34 | 14.31 | |
| Mar2024 | 9.92 | 30.01 | |
| Mar2023 | 7.63 | 49.32 | |
| Mar2022 | 5.11 | -39.24 | |
| Mar2021 | 8.41 | - | |
Other Financial Ratios of TORRENT PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Profit After Tax (PAT) Margin ratio of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹149,770.8 Cr | 1.9% | 12.3% | 49.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,999.0 Cr | 3.6% | 7% | 15.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,139.0 Cr | 1.1% | 5.8% | 14.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,664.0 Cr | 1.8% | 5.9% | 14.8% | Stock Analytics | |
| CIPLA | ₹107,685.0 Cr | 1.6% | 0.2% | -5.4% | Stock Analytics | |
| MANKIND PHARMA | ₹92,377.5 Cr | 1.5% | 8.7% | -5% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 1.9% |
12.3% |
49.2% |
| SENSEX | -2.5% |
-6.1% |
7% |
You may also like the below Video Courses